SG11202108764SA - Matrix extracellular phosphoglycoprotein (mepe) variants and uses thereof - Google Patents
Matrix extracellular phosphoglycoprotein (mepe) variants and uses thereofInfo
- Publication number
- SG11202108764SA SG11202108764SA SG11202108764SA SG11202108764SA SG11202108764SA SG 11202108764S A SG11202108764S A SG 11202108764SA SG 11202108764S A SG11202108764S A SG 11202108764SA SG 11202108764S A SG11202108764S A SG 11202108764SA SG 11202108764S A SG11202108764S A SG 11202108764SA
- Authority
- SG
- Singapore
- Prior art keywords
- mepe
- variants
- matrix extracellular
- extracellular phosphoglycoprotein
- phosphoglycoprotein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962806939P | 2019-02-18 | 2019-02-18 | |
US201962862842P | 2019-06-18 | 2019-06-18 | |
PCT/US2020/017189 WO2020171979A1 (en) | 2019-02-18 | 2020-02-07 | Matrix extracellular phosphoglycoprotein (mepe) variants and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202108764SA true SG11202108764SA (en) | 2021-09-29 |
Family
ID=69771167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202108764SA SG11202108764SA (en) | 2019-02-18 | 2020-02-07 | Matrix extracellular phosphoglycoprotein (mepe) variants and uses thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200263251A1 (en) |
EP (1) | EP3927843A1 (en) |
JP (1) | JP2022520660A (en) |
KR (1) | KR20210136037A (en) |
CN (1) | CN113544285A (en) |
AU (1) | AU2020224073A1 (en) |
CA (1) | CA3130092A1 (en) |
IL (1) | IL285622A (en) |
MX (1) | MX2021009979A (en) |
SG (1) | SG11202108764SA (en) |
WO (1) | WO2020171979A1 (en) |
-
2020
- 2020-02-07 SG SG11202108764SA patent/SG11202108764SA/en unknown
- 2020-02-07 AU AU2020224073A patent/AU2020224073A1/en not_active Abandoned
- 2020-02-07 WO PCT/US2020/017189 patent/WO2020171979A1/en unknown
- 2020-02-07 JP JP2021547855A patent/JP2022520660A/en active Pending
- 2020-02-07 CA CA3130092A patent/CA3130092A1/en active Pending
- 2020-02-07 EP EP20709932.6A patent/EP3927843A1/en not_active Withdrawn
- 2020-02-07 MX MX2021009979A patent/MX2021009979A/en unknown
- 2020-02-07 KR KR1020217030161A patent/KR20210136037A/en unknown
- 2020-02-07 US US16/784,829 patent/US20200263251A1/en not_active Abandoned
- 2020-02-07 CN CN202080019807.3A patent/CN113544285A/en active Pending
-
2021
- 2021-08-15 IL IL285622A patent/IL285622A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2020224073A1 (en) | 2021-09-16 |
US20200263251A1 (en) | 2020-08-20 |
IL285622A (en) | 2021-09-30 |
CN113544285A (en) | 2021-10-22 |
WO2020171979A1 (en) | 2020-08-27 |
KR20210136037A (en) | 2021-11-16 |
JP2022520660A (en) | 2022-03-31 |
EP3927843A1 (en) | 2021-12-29 |
MX2021009979A (en) | 2021-12-10 |
AU2020224073A8 (en) | 2021-10-07 |
CA3130092A1 (en) | 2020-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
ZA202203580B (en) | Il-17a modulators and uses thereof | |
IL287781A (en) | Clec12a-binding polypeptides and uses thereof | |
EP3985014A4 (en) | Romo1-derived antimicrobial peptides and variants thereof | |
SG11202111711PA (en) | Cd33-binding polypeptides and uses thereof | |
GB201813678D0 (en) | Acylated calcitonin mimetics | |
ZA202203618B (en) | Mmup monomer variant and application thereof | |
ZA202203568B (en) | Mnep monomer variant and application thereof | |
PL4013969T3 (en) | Tightening element | |
GB2567869B (en) | Toughened humidity/thermal resistant cyanoacrylate compositions | |
CA187196S (en) | Wearable blanket | |
IL287753A (en) | Masp inhibitory compounds and uses thereof | |
EP3706771A4 (en) | Bcl9 peptides and variants thereof | |
EP4047057A4 (en) | Quencher and uses thereof | |
GB2603645B (en) | Polypeptides having anti-senescent effects and uses thereof | |
EP4006048A4 (en) | Novel micropeptide hmmw and application thereof | |
IL285622A (en) | Matrix extracellular phosphoglycoprotein (mepe) variants and uses thereof | |
GB201909053D0 (en) | Compression | |
EP3804498A4 (en) | Threshing cylinder | |
EP3994582A4 (en) | Hardware-based memory compression | |
IL290003A (en) | A tissue-adhesive matrix and uses thereof | |
IL277441A (en) | Lfa3 variants and compositions and uses thereof | |
GB202204420D0 (en) | Crypto-erasure via internal and/or external action | |
GB201913168D0 (en) | Fingernail display system | |
GB201905509D0 (en) | Pharmaceutical compositions and associated lits and uses |